Metabolic studies of estrogen- and tamoxifen-treated human breast cancer cells by nuclear magnetic resonance spectroscopy.

The effects of 17 beta-estradiol treatment versus tamoxifen on the metabolism of human breast cancer T47D-clone 11 cells were studied by noninvasive 31P and 13C nuclear magnetic resonance techniques. 31P nuclear magnetic resonance spectra revealed differences between estrogen and tamoxifen treated cells. The steady state content of phosphorylcholine and of the nucleoside diphosphates was higher in the tamoxifen treated cells by 33 and 140%, respectively, relative to estrogen treated cells. The intracellular pH of 7.2 and the content of the nucleoside triphosphates, Pi, phosphocreatine, glycerolphosphorylcholine, and glycerolphosphorylethanolamine and uridine diphosphoglucose remained the same in both treatments. Glucose utilization and subsequent lactate, glutamate, alanine, and glycerol 3-phosphate synthesis were monitored on line following administration of specifically labeled [13C]glucose. In estrogen treated cells the rate of lactate production via glycolysis was 560 fmol/cell/h and the initial rate of 13C labeling of the glutamate pool via the Krebs cycle was 6.8 fmol/cell/h. In the tamoxifen treated cells these rates were 2-fold lower, at 250 and 2.9 fmol/cell/h for lactate and glutamate labeling, respectively. In estrogen treated cells, the calculated content of glutamate (19 fmol/cell), alanine (11 fmol/cell), and glycerol 3-phosphate (8 fmol/cell) was higher than in tamoxifen treated cells, where only glutamate labeling was detected (13 fmol/cell). The observed differences in the in vivo kinetics of glucose metabolism may provide a sensitive measure for detecting the response of human breast cancer cells to estrogen versus tamoxifen treatments.

[1]  A. Manni,et al.  Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy , 1980, Cancer.

[2]  M. Lippman,et al.  Effect of estrogens and antiestrogens on growth-regulatory enzymes in human breast cancer cells in tissue culture. , 1985, Cancer research.

[3]  C. Sonnenschein,et al.  Control of cell proliferation: evidence for negative control on estrogen-sensitive T47D human breast cancer cells. , 1986, Cancer research.

[4]  N. Gordon,et al.  Influence of tamoxifen and estradiol on the growth of human breast cancer cells in vitro. , 1986, Cancer research.

[5]  M. Thomas,et al.  Effects of 17 beta-estradiol and R5020 on glucose-6-phosphate dehydrogenase activity in MCF-7 human breast cancer cells: a cytochemical assay. , 1987, Cancer research.

[6]  D. Edwards,et al.  Estrogen induced synthesis of specific proteins in human breast cancer cells. , 1980, Biochemical and biophysical research communications.

[7]  B. Katzenellenbogen,et al.  Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[8]  C. Meijer,et al.  Estrogen receptors in human breast cancer , 1982 .

[9]  B. Katzenellenbogen,et al.  Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells. , 1984, Cancer research.

[10]  S. Bates,et al.  Characterization of estrogen responsive transforming activity in human breast cancer cell lines. , 1986, Cancer research.

[11]  D. Edwards,et al.  Estrogen regulation of specific proteins as a mode of hormone action in human breast cancer. , 1983, Biomembranes.

[12]  Predicting response to endocrine therapy in human breast cancer: a hypothesis. , 1976, Science.

[13]  H. Rochefort,et al.  Effects of plasma estrogen sulfates in mammary cancer cells. , 1980, Endocrinology.

[14]  E. Gelmann,et al.  Use of two MCF-7 cell variants to evaluate the growth regulatory potential of estrogen-induced products. , 1986, Cancer research.

[15]  B. Katzenellenbogen,et al.  Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. , 1987, Cancer research.

[16]  M. Neeman,et al.  Adaptation of culture methods for NMR studies of anchorage‐dependent cells , 1988, Magnetic resonance in medicine.

[17]  G. Batist,et al.  Differences in phosphate metabolite levels in drug-sensitive and -resistant human breast cancer cell lines determined by 31P magnetic resonance spectroscopy. , 1986, Cancer research.

[18]  R. Paridaens,et al.  Estrogen conjugates and serum factors mediating the estrogenic trophic effect on MCF-7 cell growth. , 1987, Cancer research.

[19]  R. Derynck,et al.  Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells , 1987, Cell.

[20]  T R Brown,et al.  High-resolution 13C nuclear magnetic resonance studies of glucose metabolism in Escherichia coli. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Cau,et al.  Early alterations at the plasma membrane of breast cancer cell lines in response to estradiol and hydroxytamoxifen , 1986, Molecular and Cellular Endocrinology.

[22]  D. Zava,et al.  Estrogen receptor-mediated and cytotoxic effects of the antiestrogens tamoxifen and 4-hydroxytamoxifen. , 1984, Cancer research.

[23]  J. Field,et al.  Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7. , 1983, Cancer research.

[24]  J. S. Cohen,et al.  Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy. , 1987, The Journal of biological chemistry.

[25]  R G Shulman,et al.  Applications of NMR to studies of tissue metabolism. , 1986, Annual review of biophysics and biophysical chemistry.

[26]  R. Baxter,et al.  CMR as a Probe for Metabolic Pathways in vivo , 1983 .

[27]  C. Sonnenschein,et al.  Mechanism of estrogen action on cellular proliferation: evidence for indirect and negative control on cloned breast tumor cells. , 1984, Biochemical and biophysical research communications.

[28]  W. McGuire,et al.  Nuclear estrogen receptor release from antiestrogen suppression: amplified induction of progesterone receptor in MCF-7 human breast cancer cells. , 1981, Endocrinology.

[29]  C. Osborne,et al.  Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture. , 1984, Cancer research.

[30]  D. Chalbos,et al.  Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). , 1982, The Journal of clinical endocrinology and metabolism.

[31]  M. Neeman,et al.  31P-NMR studies of phosphate transfer rates in T47D human breast cancer cells. , 1987, Biochimica et biophysica acta.

[32]  P. Darbre,et al.  Effects of estradiol and tamoxifen on human breast cancer cells in serum-free culture. , 1984, Cancer research.

[33]  W. McGuire,et al.  Lactate dehydrogenase in estrogen-responsive human breast cancer cells. , 1978, Cancer research.

[34]  R. Lyon,et al.  Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy. , 1988, Cancer research.

[35]  R. B. Moon,et al.  Determination of intracellular pH by 31P magnetic resonance. , 1973, The Journal of biological chemistry.

[36]  D L Foxall,et al.  Continuous perfusion of mammalian cells embedded in agarose gel threads. , 1984, Experimental cell research.

[37]  W. McGuire,et al.  Androgen action through estrogen receptor in a human breast cancer cell line. , 1978, Endocrinology.

[38]  R. Mikkelsen,et al.  Perfusion of cell spheroids for study by NMR spectroscopy , 1987 .

[39]  T. Ng,et al.  Application ofin vivo NMR spectroscopy to cancer , 1984, Magnetic resonance in medicine.

[40]  C. Sonnenschein,et al.  But ... are estrogens per se growth-promoting hormones? , 1980, Journal of the National Cancer Institute.

[41]  A. Sapino,et al.  Estrogen- and tamoxifen-induced rearrangement of cytoskeletal and adhesion structures in breast cancer MCF-7 cells. , 1986, Cancer research.

[42]  R. Shiu,et al.  Role of polyamines in estradiol-induced growth of human breast cancer cells. , 1985, Cancer research.

[43]  D. Carney,et al.  Continuous culture and soft agarose cloning of multiple human breast carcinoma cell lines in serum-free medium. , 1984, Cancer research.

[44]  K. Uğurbil,et al.  High-resolution 13 C nuclear magnetic resonance studies of glucose metabolism in Escherichia coli ( glycolysis / glucose utilization / anomeric specificity / anaerobic / aerobic ) , 2022 .

[45]  B. Katzenellenbogen,et al.  Characterization and quantitation of antiestrogen binding sites in estrogen receptor-positive and -negative human breast cancer cell lines. , 1983, Cancer research.

[46]  C. Osborne,et al.  Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. , 1983, Cancer research.